Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exemestane With and Without Bicalutamide in Advanced Prostate Cancer
NCT00031889Phase 2Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Aug 2001
- Primary completion
- Jun 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of exemestane in prostate cancer (PCa) (2 arms), sponsored by Swiss Group for Clinical Cancer Research. Primary endpoints: Efficacy based on PSA response and Tolerability. Started Aug 2001; status: completed.
02
Drugs
exemestane
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00031889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00031889.